Category Health/Medical

New Immunotherapy Technique holds Promise for Curing Food Allergies

Regulatory DC immunotherapy can be effective for food allergies and suggest that induction of Foxp3− regulatory T cells might be a useful strategy for tolerance induction in this context.

Regulatory DC immunotherapy can be effective for food allergies and suggest that induction of Foxp3− regulatory T cells might be a useful strategy for tolerance induction in this context.

A new immunotherapy technique has been developed that nearly eliminates the allergic response to peanut and egg white proteins in food-allergic mice, reducing the anaphylactic response by up to 90% with only one treatment. The findings open the door to test this new allergy treatment in “humanized mice” – mice with non-existent immune systems implanted with cells from a human immune system, eg, from a peanut-allergic person. With Health Canada approval, the first human trial could begin in about one year, Gordon said.

“If we can reliably ‘cure’ food allergies, or related conditions such as asthma or aut...

Read More

Neu5Gc in Red Meat and Organs may pose a significant health hazard

Our immune system sees Neu5GC as foreign and antibodies are made to attack it. This cancause inflammation and may promote cancer cell growth.

Our immune system sees Neu5GC as foreign and antibodies are made to attack it. This cancause inflammation and may promote cancer cell growth.

Neu5Gc, a non-human sialic acid sugar molecule common in red meat that increases the risk of tumor formation in humans, is also prevalent in pig organs, with concentrations increasing as the organs are cooked, a study by researchers from the UC Davis School of Medicine and Xiamen University School of Medicine has found. The research suggests that Neu5Gc may pose a significant health hazard among those who regularly consume organ meats from pigs.

Neu5Gc is naturally found on cell surfaces in most mammals but not in humans. It gets incorporated into human cells by eating meats, organs and some dairy products...

Read More

Boosting Levels of known Antioxidant may help Resist Age-related Decline

The chemical structure of glutathione, an antioxidant that may help resist the toxins that are an underlying cause of aging. Credit: Graphic courtesy of Oregon State University

The chemical structure of glutathione, an antioxidant that may help resist the toxins that are an underlying cause of aging. Credit: Graphic courtesy of Oregon State University

OSU researchers have found that a specific detoxification compound, glutathione, helps resist the toxic stresses of everyday life – but its levels decline with age and this sets the stage for a wide range of age-related health problems. A new study also highlighted a compound – N-acetyl-cysteine, or NAC — that is already used in high doses in medical detoxification emergencies. But the researchers said that at much lower levels NAC might help maintain glutathione levels and prevent the routine metabolic declines associated with aging.

Decline of these detoxification pathways are causally linked to cardiovascular dis...

Read More

Inflammation Triggers unsustainable Immune response to Chronic Viral Infection

Under the influence of interferons, chronic viral infections cause strong inflammation. This causes the B cells to initiate an inadequate immune response which first optimizes the production of antibodies for a short period, but then rapidly subsides. (Image: University of Basel)

Under the influence of interferons, chronic viral infections cause strong inflammation. This causes the B cells to initiate an inadequate immune response which first optimizes the production of antibodies for a short period, but then rapidly subsides. (Image: University of Basel)

Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection. These results may open up new avenues for vaccine development. In the course of an infection or upon vaccination, B cells, produce antibodies that bind viruses and inactivate them. In the context of chronic viral infections such as HIV or hepatitis C virus, however, antibody production by B cells is quantitatively inadequate and starts too late.

A team of scientists...

Read More